Carani Sanjeevi
Director/Miembro de la Junta en Allarity Therapeutics Europe ApS .
Cargos activos de Carani Sanjeevi
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | 01/01/1996 | - |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Director/Miembro de la Junta | - | - |
Historial de carrera de Carani Sanjeevi
Antiguos cargos conocidos de Carani Sanjeevi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Miembro de la Junta | 18/12/2018 | 07/10/2020 |
| Independent Dir/Board Member | 18/12/2018 | 07/10/2020 | |
| Center for Molecular Medicine (Sweden) | Corporate Officer/Principal | - | - |
| Cadila Pharmaceuticals Sweden AB | Director/Miembro de la Junta | - | - |
Oncology Venture Sweden AB
 Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Director/Miembro de la Junta | 01/01/2015 | - |
Estadísticas
Internacional
| Dinamarca | 4 |
| Suecia | 4 |
Operativa
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
| Cadila Pharmaceuticals Sweden AB | Health Technology |
| Center for Molecular Medicine (Sweden) |
- Bolsa de valores
- Insiders
- Carani Sanjeevi
- Experiencia
